SeaStar Medical Holding Corporation (ICU)
ICU trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1831868/000143774926009797/0001437749-26-009797-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | ICU on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001831868 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.2M |
| Net income | -$12.2M |
| Operating income | -$12.2M |
| Net margin | -984.6% |
| Operating margin | -986.6% |
| Revenue growth | +814.1% |
| Cash | $12.0M |
| Total assets | $14.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.7× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "The Company believes that these conditions raise substantial doubt about its ability to continue as a going concern." | 10-Q 2026-11-12 |
| Cash and burn | $4.0M cash; operating cash flow -$3.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 5,315,967 (2026-11-01); 36,047,134 a year earlier; 36,979,724 three years earlier. 1y figure adjusted for splits (1-for-10 overall); 3y figure adjusted for splits (1-for-250 overall). | Cover page 2026-11-01 |
| Reverse splits, 3 years | 2; latest 1-for-10 on 2026-01-05 | Source 2026-01-05 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2025-11-20 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | WithumSmith+Brown, PC, East Brunswick, New Jersey, United States | PCAOB Form AP 2026-03-30 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $9K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $635K | -$4.5M | -$3.4M | $4.0M | $0 | $2.2M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $615K | -$3.7M | -$3.0M | $7.0M | $134K | $1.7M | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $495K | -$3.5M | -$2.8M | $9.3M | $331K | $1.4M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $420K | -$2.9M | -$4.1M | $12.0M | $525K | $1.2M | 10-K 2026-03-25 |
| Q3 2025 2025-09-30 | $183K | -$3.5M | -$3.8M | $13.8M | $0 | $881K | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $338K | -$2.0M | -$3.0M | $6.3M | $0 | $766K | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $293K | -$3.8M | -$2.7M | $5.3M | $363K | $428K | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $67K | -$4.4M | -$4.7M | $1.8M | $574K | $135K | 10-K 2026-03-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-3 | 2026-10-30 |
| Latest annual report FORM 10-K | 10-K | 2026-03-25 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-12 |
| Latest current report FORM 8-K | 8-K | 2026-11-12 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 547 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -55.4% |
| 1 month | -76.7% |
| 3 months | -73.6% |
| Year to date | -65.1% |
| 1 year | -81.8% |
| From 52-week high | -83.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| ICUCW | SeaStar Medical Holding Corporation Warrant | $0.0082 |
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | $0.1065 | +17.68% | $4.5M |
| SNOA | Sonoma Pharmaceuticals Inc. | $0.8802 | -19.25% | $4.5M |
| INBS | Intelligent Bio Solutions Inc. | $1.50 | -16.20% | $5.0M |
| NVNO | enVVeno Medical Corporation | $5.95 | -3.65% | $4.1M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
| NMTC | NeuroOne Medical Technologies Corporation | $0.7450 | -0.01% | $6.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier